Immunovant, Inc. (IMVT)
25.77
+0.13
(+0.51%)
USD |
NASDAQ |
Feb 13, 14:23
Immunovant Cash from Investing (Quarterly) : 0.00 for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -- |
| Revvity, Inc. | -20.45M |
| Viridian Therapeutics, Inc. | 126.08M |
| Plus Therapeutics, Inc. | 1.297M |
| Nutriband, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -92.32M |
| Cash from Financing (Quarterly) | 564.60M |
| Free Cash Flow | -423.09M |
| Free Cash Flow Per Share (Quarterly) | -0.5086 |
| Free Cash Flow to Equity (Quarterly) | -92.32M |
| Free Cash Flow to Firm (Quarterly) | -92.32M |
| Free Cash Flow Yield | -9.48% |